George Sellers
Stock Analyst at Stephens & Co.
(1.88)
# 1,906
Out of 4,667 analysts
57
Total ratings
33.33%
Success rate
-5.17%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUTR Cutera | Maintains: Overweight | $10 → $5 | $0.30 | +1,553.99% | 11 | Aug 9, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $41.81 | +62.64% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $187.43 | +54.72% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $57.26 | +1.29% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $77.20 | +130.57% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $17.18 | +39.70% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $10.35 | +73.91% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $44.78 | +60.79% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.40 | +257.14% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $7.98 | +213.28% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $57 | $26.32 | +116.57% | 6 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $71 | $141.44 | -49.80% | 4 | May 8, 2023 |
Cutera
Aug 9, 2024
Maintains: Overweight
Price Target: $10 → $5
Current: $0.30
Upside: +1,553.99%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $41.81
Upside: +62.64%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $187.43
Upside: +54.72%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $57.26
Upside: +1.29%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $77.20
Upside: +130.57%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $17.18
Upside: +39.70%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $10.35
Upside: +73.91%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $44.78
Upside: +60.79%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.40
Upside: +257.14%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $7.98
Upside: +213.28%
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $26.32
Upside: +116.57%
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $141.44
Upside: -49.80%